FIELD: medicine; oncology.
SUBSTANCE: invention relates to the field of medicine, namely oncology; it is intended for the treatment or prevention of cancer in mammals. To induce apoptosis in proliferating cancer cells, a composition containing therapeutically effective amount of pyronaridine (hereinafter – PND) or its pharmaceutically acceptable salt is injected to a mammal at least every second or third day for at least two weeks. The therapeutically effective amount of PND or its pharmaceutically acceptable salt is at least 100 mg.
EFFECT: use of the invention makes it possible to induce apoptosis in proliferating cancer cells.
12 cl, 13 dwg, 6 ex
| Title | Year | Author | Number |
|---|---|---|---|
| RECOMBINANT ALBUMEN WITH ANTI-CANCER EFFECT, GENE CODING IT, AND APPLICATION THEREOF | 2003 |
|
RU2333221C2 |
| LIGANDS TO RECEPTOR OF FOLLICLE-STIMULATING HORMONE (FSH) IN DIAGNOSTICS AND TREATMENT OF TUMORS | 2017 |
|
RU2755000C2 |
| TARGETED EXPOSURE TO TRASTUZUMAB-RESISTANT HER2+ BREAST CANCER BY HER3-TARGETED NANOPARTICLES | 2015 |
|
RU2692104C2 |
| CYCLIC C-TERMINAL PEPTIDE OF ACETYLCHOLINESTERASE IN TREATING OR PREVENTING CANCER OR METASTASIS | 2015 |
|
RU2711161C2 |
| MEDICINAL EXTRACTS OF AMBROSIA PLANTS | 2016 |
|
RU2763021C2 |
| METHOD OF TREATING CANCER (VERSIONS) | 2006 |
|
RU2447889C2 |
| METHOD OF IDENTIFICATION AGENT BASED ON HIGH THROUGHPUT SCREENING | 2007 |
|
RU2486247C2 |
| RECEPTOR TARGETING CONSTRUCTS AND USES THEREOF | 2015 |
|
RU2682335C2 |
| METHODS FOR CANCER TREATMENT USING AUTOPHAGY INHIBITOR BASED ON THIOXANTHONE | 2011 |
|
RU2627588C2 |
| METHOD OF USING AXL AS MARKER OF EPITHELIAL-MESENCHYMAL TRANSITION | 2010 |
|
RU2586493C2 |
